tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vicarious Surgical price target lowered to $7 from $8.50 at Piper Sandler

Piper Sandler lowered the firm’s price target on Vicarious Surgical (RBOT) to $7 from $8.50 and keeps a Neutral rating on the shares following quarterly results. Most notably, the company removed its goal for first clinical use by year-end and instead is focused on completing a fully integrated, production-equivalent system enabling design lock and initiating full system V&V, the firm says.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1